» Articles » PMID: 37716974

Exosomes Derived from LPS-preconditioned Bone Marrow-derived MSC Modulate Macrophage Plasticity to Promote Allograft Survival Via the NF-κB/NLRP3 Signaling Pathway

Overview
Publisher Biomed Central
Specialty Biotechnology
Date 2023 Sep 16
PMID 37716974
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study investigated whether exosomes from LPS pretreated bone marrow mesenchymal stem cells (LPS pre-MSCs) could prolong skin graft survival.

Methods: The exosomes were isolated from the supernatant of MSCs pretreated with LPS. LPS pre-Exo and rapamycin were injected via the tail vein into C57BL/6 mice allografted with BALB/c skin; graft survival was observed and evaluated. The accumulation and polarization of macrophages were examined by immunohistochemistry. The differentiation of macrophages in the spleen was analyzed by flow cytometry. For in vitro, an inflammatory model was established. Specifically, bone marrow-derived macrophages (BMDMs) were isolated and cultured with LPS (100 ng/ml) for 3 h, and were further treated with LPS pre-Exo for 24 h or 48 h. The molecular signaling pathway responsible for modulating inflammation was examined by Western blotting. The expressions of downstream inflammatory cytokines were determined by Elisa, and the polarization of macrophages was analyzed by flow cytometry.

Results: LPS pre-Exo could better ablate inflammation compared to untreated MSC-derived exosomes (BM-Exo). These loaded factors inhibited the expressions of inflammatory factors via a negative feedback mechanism. In vivo, LPS pre-Exo significantly attenuated inflammatory infiltration, thus improving the survival of allogeneic skin graft. Flow cytometric analysis of BMDMs showed that LPS pre-Exo were involved in the regulation of macrophage polarization and immune homeostasis during inflammation. Further investigation revealed that the NF-κB/NLRP3/procaspase-1/IL-1β signaling pathway played a key role in LPS pre-Exo-mediated regulation of macrophage polarization. Inhibiting NF-κB in BMDMs could abolish the LPS-induced activation of inflammatory pathways and the polarization of M1 macrophages while increasing the proportion of M2 cells.

Conclusion: LPS pre-Exo are able to switch the polarization of macrophages and enhance the resolution of inflammation. This type of exosomes provides an improved immunotherapeutic potential in prolonging graft survival.

Citing Articles

Optimizing therapeutic outcomes: preconditioning strategies for MSC-derived extracellular vesicles.

Song Y, Liang F, Tian W, Rayhill E, Ye L, Tian X Front Pharmacol. 2025; 16:1509418.

PMID: 39995418 PMC: 11847897. DOI: 10.3389/fphar.2025.1509418.


Exosomes derived from liver failure patients' plasma stimulated mesenchymal stem cells alleviate acute liver failure.

Wang Z, Ling J, You S, Zhu B Stem Cell Res Ther. 2025; 16(1):48.

PMID: 39920768 PMC: 11806533. DOI: 10.1186/s13287-025-04163-2.


Extracellular Vesicles Derived from Lipopolysaccharide-Pretreated Periodontal Ligament Stem Cells Ameliorate Inflammatory Responses in Experimental Colitis via the PI3K/AKT Signaling Pathway.

Tang S, Feng W, Li Z, Liu X, Yang T, Wei F Int J Nanomedicine. 2024; 19:11997-12013.

PMID: 39583323 PMC: 11583767. DOI: 10.2147/IJN.S494321.


Dexamethasone and IFN-γ primed mesenchymal stem cells conditioned media immunomodulates aberrant NETosis in SLE via PGE2 and IDO.

Priya K, Thacker H, Chaubey M, Rai M, Singh S, Rawat S Front Immunol. 2024; 15:1461841.

PMID: 39544931 PMC: 11560778. DOI: 10.3389/fimmu.2024.1461841.


Exosomal non-coding RNAs: Emerging insights into therapeutic potential and mechanisms in bone healing.

Shi H, Yang Y, Xing H, Jia J, Xiong W, Guo S J Tissue Eng. 2024; 15:20417314241286606.

PMID: 39371940 PMC: 11456177. DOI: 10.1177/20417314241286606.


References
1.
Uehara M, Li X, Sheikhi A, Zandi N, Walker B, Saleh B . Anti-IL-6 eluting immunomodulatory biomaterials prolong skin allograft survival. Sci Rep. 2019; 9(1):6535. PMC: 6484015. DOI: 10.1038/s41598-019-42349-w. View

2.
Hoseini Z, Sepahvand F, Rashidi B, Sahebkar A, Masoudifar A, Mirzaei H . NLRP3 inflammasome: Its regulation and involvement in atherosclerosis. J Cell Physiol. 2017; 233(3):2116-2132. DOI: 10.1002/jcp.25930. View

3.
Zahid A, Li B, Kombe Kombe A, Jin T, Tao J . Pharmacological Inhibitors of the NLRP3 Inflammasome. Front Immunol. 2019; 10:2538. PMC: 6842943. DOI: 10.3389/fimmu.2019.02538. View

4.
Zheng Y, Li Y, Ran X, Wang D, Zheng X, Zhang M . Mettl14 mediates the inflammatory response of macrophages in atherosclerosis through the NF-κB/IL-6 signaling pathway. Cell Mol Life Sci. 2022; 79(6):311. PMC: 9124663. DOI: 10.1007/s00018-022-04331-0. View

5.
Zhao C, Zhao W . NLRP3 Inflammasome-A Key Player in Antiviral Responses. Front Immunol. 2020; 11:211. PMC: 7040071. DOI: 10.3389/fimmu.2020.00211. View